[Part I. Financial Information](index=4&type=section&id=PART%20I.%20FINANCIAL%20INFORMATION) [Item 1. Unaudited Financial Statements](index=4&type=section&id=ITEM%201.%20Unaudited%20Financial%20Statements) Presents Abri SPAC I, Inc.'s unaudited condensed financial statements for Q1 2023 and 2022, encompassing balance sheets, operations, equity, cash flows, and accompanying notes [Condensed Balance Sheets](index=4&type=section&id=Condensed%20Balance%20Sheets) As of March 31, 2023, total assets were **$13.69 million**, with **$13.23 million** in Trust Account marketable securities, total liabilities **$7.15 million**, and a stockholders' deficit of **$6.61 million** Condensed Balance Sheet Data (as of March 31, 2023 vs. December 31, 2022) | Balance Sheet Item | March 31, 2023 (Unaudited) ($) | December 31, 2022 ($) | | :--- | :--- | :--- | | **Assets** | | | | Cash | $279,317 | $381,293 | | Marketable securities held in Trust Account | $13,233,912 | $12,841,399 | | **Total Assets** | **$13,691,648** | **$13,475,155** | | **Liabilities & Equity** | | | | Total current liabilities | $2,706,156 | $2,554,817 | | Promissory notes, related party | $1,321,784 | $1,146,784 | | Convertible promissory notes, related party | $1,600,000 | $1,250,000 | | **Total Liabilities** | **$7,154,454** | **$6,469,277** | | Common stock subject to possible redemption | $13,148,995 | $12,841,399 | | **Total stockholders' deficit** | **($6,611,801)** | **($5,835,521)** | [Condensed Statements of Operations](index=5&type=section&id=Condensed%20Statements%20of%20Operations) For Q1 2023, the company reported a net loss of **$468,684**, a significant reduction from **$1,322,607** in Q1 2022, driven by lower operating expenses and higher interest income Condensed Statements of Operations (Three Months Ended) | Line Item | March 31, 2023 (Unaudited) ($) | March 31, 2022 (Unaudited) ($) | | :--- | :--- | :--- | | Total operating expenses | $577,856 | $1,395,709 | | Loss from operations | ($577,856) | ($1,395,709) | | Interest income | $142,010 | $5,344 | | Change in fair value of warrant liabilities | ($8,838) | $67,758 | | **Net loss** | **($468,684)** | **($1,322,607)** | | Basic and diluted net loss per share, non-redeemable | ($0.26) | ($0.32) | [Condensed Statements of Cash Flows](index=7&type=section&id=Condensed%20Statements%20of%20Cash%20Flows) For Q1 2023, net cash used in operations was **$234,463**, investing activities used **$392,513**, while financing provided **$525,000**, resulting in a cash balance decrease to **$279,317** Condensed Statements of Cash Flows (Three Months Ended March 31) | Cash Flow Activity | 2023 (Unaudited) ($) | 2022 (Unaudited) ($) | | :--- | :--- | :--- | | Net cash used in operating activities | ($234,463) | ($449,940) | | Net cash used in investing activities | ($392,513) | $0 | | Net cash provided by financing activities | $525,000 | $300,000 | | **Net Change in Cash** | **($101,976)** | **($149,940)** | | Cash - End of period | $279,317 | $5,002 | [Notes to Financial Statements (Unaudited)](index=8&type=section&id=Notes%20to%20Financial%20Statements%20(Unaudited)) Provides detailed information on the company's organization, accounting policies, related party transactions, commitments including the DLQ merger, stockholders' deficit, warrants, fair value measurements, and income taxes - The company operates as a SPAC, focused on organizational tasks, IPO, and identifying a business combination target, without core operations commenced[43](index=43&type=chunk)[44](index=44&type=chunk) - On September 9, 2022, the company entered a Merger Agreement with DLQ, Inc., with a **$114 million** consideration payable in Abri Common Stock shares[153](index=153&type=chunk)[154](index=154&type=chunk) - The deadline for completing an initial business combination has been extended to **June 12, 2023**, with a potential further extension to **August 12, 2023**, via Trust Account deposits[61](index=61&type=chunk)[62](index=62&type=chunk) - Management identified substantial doubt about the company's ability to continue as a going concern due to insufficient working capital until a business combination or one year from filing[64](index=64&type=chunk)[68](index=68&type=chunk) [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=29&type=section&id=ITEM%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Provides management's perspective on the company's financial condition and results, covering net loss, liquidity, capital resources, and the pending merger agreement with DLQ, Inc - The company operates as a blank check entity, with all activities since inception focused on organizational tasks, IPO, and identifying a business combination target[145](index=145&type=chunk)[146](index=146&type=chunk) Results of Operations Comparison (Three Months Ended March 31) | Description | 2023 ($) | 2022 ($) | | :--- | :--- | :--- | | Net Loss | $468,684 | $1,322,607 | | Key Drivers | Lower operating costs ($578k vs $1.4M), higher interest income ($142k vs $5k) | Higher operating costs | - As of March 31, 2023, the company reported **$279,317** in cash, a working capital deficiency of **$2,248,420**, and **$13,233,912** held in the Trust Account[161](index=161&type=chunk) - The business combination deadline was extended to **June 12, 2023**, following **$45.9 million** in share redemptions in December 2022, with a potential extension to **August 12, 2023**[162](index=162&type=chunk)[163](index=163&type=chunk) [Item 3. Quantitative and Qualitative Disclosures about Market Risk](index=33&type=section&id=ITEM%203.%20Quantitative%20and%20Qualitative%20Disclosures%20about%20Market%20Risk) As a smaller reporting company, the company is exempt from providing disclosures under this item - Disclosures under this item are not required as the company is a smaller reporting company[175](index=175&type=chunk) [Item 4. Controls and Procedures](index=33&type=section&id=ITEM%204.%20Controls%20and%20Procedures) Management concluded that disclosure controls and procedures were ineffective as of March 31, 2023, due to a material weakness in financial close processes, with a remediation plan underway - As of March 31, 2023, management concluded the company's disclosure controls and procedures were not effective[177](index=177&type=chunk) - Ineffectiveness stems from a material weakness in the financial close process, specifically regarding classification of reinvested interest from Trust Account marketable securities in cash flow statements[178](index=178&type=chunk) - A remediation plan is underway to enhance internal communications with financial advisors and improve access to accounting literature and research[179](index=179&type=chunk) [Part II. Other Information](index=34&type=section&id=PART%20II.%20OTHER%20INFORMATION) [Item 1. Legal Proceedings](index=34&type=section&id=ITEM%201.%20Legal%20Proceedings) The company has no legal proceedings to report for the period - No legal proceedings to report[182](index=182&type=chunk) [Item 1A. Risk Factors](index=34&type=section&id=ITEM%201A.%20Risk%20Factors) No material changes to risk factors previously disclosed in the Annual Report on Form 10-K filed March 30, 2023 - No material changes to risk factors disclosed in the Annual Report on Form 10-K filed with the SEC on March 30, 2023[185](index=185&type=chunk) [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=34&type=section&id=ITEM%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The company reports no unregistered sales of equity securities or use of proceeds for the period - No unregistered sales of equity securities or use of proceeds to report[186](index=186&type=chunk) [Item 6. Exhibits](index=35&type=section&id=ITEM%206.%20Exhibits) Lists exhibits filed as part of the Quarterly Report, including officer certifications and Inline XBRL documents - The report includes exhibits such as CEO and CFO certifications (31.1, 31.2, 32) and Inline XBRL data files (101 series)[188](index=188&type=chunk)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FORM 10-K For the fiscal year ended December 31, 2022 or For the transition period from _____________ to ________________ Commission file number: 001-40723 ABRI SPAC I, INC. (Exact name of registrant as specified in its charter) | --- | |------------------------------ ...

[PART I. FINANCIAL INFORMATION](index=4&type=section&id=PART%20I.%20FINANCIAL%20INFORMATION) [Unaudited Financial Statements](index=4&type=section&id=ITEM%201.%20Unaudited%20Financial%20Statements) The unaudited financial statements for the period ended September 30, 2022, show a net loss and stockholders' deficit, driven by SPAC formation and business combination search activities [Condensed Balance Sheets](index=4&type=section&id=Condensed%20Balance%20Sheets) Condensed Balance Sheet Data (Unaudited) | Account | Sep 30, 2022 | Dec 31, 2021 | | :--- | :--- | :--- | | **Assets** | | | | Cash | $175,074 | $154,942 | | Marketable securities held in Trust Account | $58,175,785 | $57,340,207 | | **Total Assets** | **$58,659,402** | **$57,816,739** | | **Liabilities & Equity** | | | | Total Liabilities | $5,308,674 | $2,358,398 | | Common stock subject to possible redemption | $56,021,637 | $52,323,289 | | Total stockholders' equity (deficit) | ($2,670,909) | $3,135,052 | - As of September 30, 2022, the company had a working capital deficit of **$1,622,206**, calculated from total current assets of **$483,617** and total current liabilities of **$2,105,823**[11](index=11&type=chunk)[40](index=40&type=chunk) [Condensed Statements of Operations](index=5&type=section&id=Condensed%20Statements%20of%20Operations) Condensed Statements of Operations Highlights (Unaudited) | Metric | Three Months Ended Sep 30, 2022 | Nine Months Ended Sep 30, 2022 | | :--- | :--- | :--- | | Total operating expenses | $727,702 | $2,628,016 | | Interest income | $297,022 | $378,995 | | Change in fair value of warrant liability | $32,406 | $141,408 | | **Net Loss** | **($398,274)** | **($2,107,613)** | - The net loss per non-redeemable share was **($0.24)** for the three months and **($0.78)** for the nine months ended September 30, 2022[15](index=15&type=chunk) [Condensed Statements of Changes in Stockholders' Equity (Deficit)](index=6&type=section&id=Condensed%20Statements%20of%20Changes%20in%20Stockholders%27%20Equity%20%28Deficit%29) - Total stockholders' equity shifted from a positive **$3,135,052** at the start of 2022 to a deficit of **($2,670,909)** by September 30, 2022, primarily driven by the net loss for the period and the accretion of common stock to its redemption value[16](index=16&type=chunk) [Condensed Statements of Cash Flows](index=7&type=section&id=Condensed%20Statements%20of%20Cash%20Flows) Cash Flow Summary for Nine Months Ended Sep 30, 2022 (Unaudited) | Cash Flow Activity | Amount | | :--- | :--- | | Net cash used in operating activities | ($1,079,868) | | Net cash used in investing activities | ($573,392) | | Net cash provided by financing activities | $1,673,392 | | **Net Change in Cash** | **$20,132** | - Financing activities for the nine months ended September 30, 2022, were primarily funded by proceeds from convertible promissory notes and other notes from a related party, totaling **$1.67 million**[18](index=18&type=chunk) [Notes to Financial Statements (Unaudited)](index=8&type=section&id=Notes%20to%20Financial%20Statements%20%28Unaudited%29) The notes detail the company's SPAC nature, business combination efforts including a new merger agreement, and management's conclusion of substantial doubt about its going concern ability - The company is a SPAC incorporated on **March 18, 2021**, with the purpose of effecting an Initial Business Combination, and has not commenced core operations, generating non-operating interest income from its Trust Account[20](index=20&type=chunk)[21](index=21&type=chunk) - The company extended its deadline to complete a business combination to **February 12, 2023**, by making two deposits of **$573,392** each into the Trust Account on **August 12, 2022**, and **November 1, 2022**[24](index=24&type=chunk)[37](index=37&type=chunk) - Management has concluded that there is **substantial doubt** about the company's ability to continue as a **going concern** due to its working capital deficit and the need for additional funding to sustain operations until a business combination is consummated[40](index=40&type=chunk)[41](index=41&type=chunk) - On **July 22, 2022**, the company mutually terminated its merger agreement with **Apifiny Group Inc.**, and subsequently, on **September 9, 2022**, entered into a new merger agreement with **DLQ, Inc.** for a total consideration of **$114 million** in stock[97](index=97&type=chunk)[100](index=100&type=chunk)[101](index=101&type=chunk) - The company accounts for its Private Warrants as a liability at fair value, which is re-measured each reporting period, with the fair value of the warrant liability decreasing by **$141,408** during the nine months ended September 30, 2022[52](index=52&type=chunk)[136](index=136&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=31&type=section&id=ITEM%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses the company's status as a blank check company, detailing net loss drivers, a significant working capital deficit, and substantial doubt about its going concern ability, with liquidity supported by Sponsor loans Results of Operations Summary | Period | Net Loss | Key Components | | :--- | :--- | :--- | | **Nine Months Ended Sep 30, 2022** | **$2,107,613** | Operating costs of $2,628,016, offset by interest income of $378,995 and a $141,408 gain on warrant liability | | **Three Months Ended Sep 30, 2022** | **$398,274** | Operating costs of $727,702, offset by interest income of $297,022 and a $32,406 gain on warrant liability | - The company had a working capital deficit of **$1,622,206** as of September 30, 2022, and relies on its Sponsor for loans to meet liquidity needs, raising **substantial doubt** about its ability to continue as a **going concern**[163](index=163&type=chunk)[165](index=165&type=chunk) - The company terminated its merger agreement with **Apifiny** on **July 22, 2022**, and has extended the deadline to consummate an initial business combination to **February 12, 2023**[155](index=155&type=chunk)[157](index=157&type=chunk) - Contractual obligations include a **$10,000** monthly fee to the Sponsor for administrative support and a deferred underwriting commission of **$1.5 million** (**3.0%** of gross proceeds) payable upon completion of an Initial Business Combination[167](index=167&type=chunk)[168](index=168&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=35&type=section&id=ITEM%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) As a smaller reporting company, the company is not required to provide disclosures regarding quantitative and qualitative market risk - The company is not required to make disclosures under this item as it qualifies as a smaller reporting company[173](index=173&type=chunk) [Controls and Procedures](index=35&type=section&id=ITEM%204.%20Controls%20and%20Procedures) Management concluded that the company's disclosure controls and procedures were effective as of September 30, 2022, with no material changes to internal control over financial reporting during the quarter - Based on an evaluation as of September 30, 2022, the company's principal executive officer and principal financial officer concluded that disclosure controls and procedures were **effective**[175](index=175&type=chunk) - No changes in internal control over financial reporting occurred during the most recent fiscal quarter that materially affected, or are reasonably likely to materially affect, internal controls[177](index=177&type=chunk) [PART II. OTHER INFORMATION](index=36&type=section&id=PART%20II.%20OTHER%20INFORMATION) [Legal Proceedings](index=36&type=section&id=ITEM%201.%20Legal%20Proceedings) The company reports no legal proceedings - The company has no legal proceedings to report[179](index=179&type=chunk) [Risk Factors](index=36&type=section&id=ITEM%201A.%20Risk%20Factors) The company highlights risks including increased SPAC competition, potential adverse effects from proposed SEC rules, and the new 1% excise tax on stock redemptions from the Inflation Reduction Act of 2022 - A substantial increase in the number of SPACs has **intensified competition** for attractive target companies, potentially increasing costs and delaying or preventing the company from completing a business combination[181](index=181&type=chunk)[182](index=182&type=chunk)[183](index=183&type=chunk) - Proposed SEC rules on March 30, 2022, related to SPACs could, if adopted, **materially and adversely affect** the company's ability to negotiate and complete its Initial Business Combination and may increase associated costs and time[185](index=185&type=chunk) - The Inflation Reduction Act of 2022 imposes a **1% excise tax** on stock repurchases by publicly traded domestic corporations after **December 31, 2022**, which may apply to redemptions of the company's common stock, potentially reducing the cash available for a business combination[187](index=187&type=chunk)[188](index=188&type=chunk)[189](index=189&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=37&type=section&id=ITEM%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The company reports no unregistered sales of equity securities or use of proceeds - None reported[190](index=190&type=chunk) [Defaults Upon Senior Securities](index=37&type=section&id=ITEM%203.%20Defaults%20Upon%20Senior%20Securities) The company reports no defaults upon senior securities - None reported[191](index=191&type=chunk) [Mine Safety Disclosures](index=37&type=section&id=ITEM%204.%20Mine%20Safety%20Disclosures) This item is not applicable to the company - Not applicable[192](index=192&type=chunk) [Other Information](index=37&type=section&id=ITEM%205.%20Other%20Information) The company reports no other information - None reported[193](index=193&type=chunk) [Exhibits](index=38&type=section&id=ITEM%206.%20Exhibits) This section lists exhibits filed with the Quarterly Report, including officer certifications and Inline XBRL documents - The report includes certifications from the Principal Executive Officer and Principal Financial Officer as required by the Sarbanes-Oxley Act[195](index=195&type=chunk) - Inline XBRL data files are included as exhibits to the report[195](index=195&type=chunk)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number: 001-40723 ABRI SPAC I, INC. (Exact Name of Registrant as Specified in Its Charter) | --- | --- | |---------------------------- ...

[PART I. FINANCIAL INFORMATION](index=4&type=section&id=PART%20I.%20FINANCIAL%20INFORMATION) This section presents the unaudited financial statements and management's analysis of ABRI SPAC I, Inc.'s financial condition and results of operations [Unaudited Financial Statements](index=4&type=section&id=ITEM%201.%20Unaudited%20Financial%20Statements) This section presents ABRI SPAC I, Inc.'s unaudited financial statements, highlighting a net loss and working capital deficit for the period [Balance Sheets](index=4&type=section&id=Balance%20Sheets) This section summarizes the company's assets, liabilities, and equity as of March 31, 2022, compared to December 31, 2021 Balance Sheet Summary (as of March 31, 2022 vs. December 31, 2021) | Metric | March 31, 2022 (Unaudited) | December 31, 2021 | | :--- | :--- | :--- | | **Total Assets** | **$57,665,728** | **$57,816,739** | | Marketable securities held in Trust Account | $57,341,407 | $57,340,207 | | Cash | $5,002 | $154,942 | | **Total Liabilities** | **$3,529,994** | **$2,358,398** | | Accounts payable and accrued expenses | $1,626,885 | $687,531 | | Due to sponsor | $300,000 | $0 | | Warrant liability | $103,109 | $170,867 | | **Total Stockholders' Equity** | **$712,944** | **$3,135,052** | - The company's cash position decreased significantly from **$154,942 to $5,002**, while liabilities increased, driven by a rise in accounts payable and a **$300,000** loan from the sponsor[12](index=12&type=chunk) [Statements of Operations](index=5&type=section&id=Statements%20of%20Operations) This section details the company's revenues, expenses, and net loss for the three months ended March 31, 2022 Statement of Operations (For the Three Months Ended March 31, 2022) | Metric | Amount | | :--- | :--- | | Loss from operations | $(1,395,709) | | Interest income | $5,344 | | Change in fair value of warrant liability | $67,758 | | **Net loss** | **$(1,322,607)** | | Basic and diluted net loss per share, non-redeemable shares | $(0.32) | - The net loss for the quarter was primarily driven by operating expenses of nearly **$1.4 million**, partially offset by a non-cash gain from the change in fair value of the warrant liability[15](index=15&type=chunk) [Statements of Changes in Stockholders' Equity](index=6&type=section&id=Statements%20of%20Changes%20in%20Stockholders%27%20Equity) This section outlines the changes in the company's stockholders' equity during the three months ended March 31, 2022 - Total stockholders' equity decreased from **$3.1 million** at the beginning of the year to **$0.7 million** as of March 31, 2022. The decrease was primarily due to the net loss of **$1.3 million** and an accretion of common stock to redemption value of **$1.1 million**, which was reclassified from additional paid-in capital[16](index=16&type=chunk) [Statements of Cash Flows](index=7&type=section&id=Statements%20of%20Cash%20Flows) This section summarizes cash flows from operating, investing, and financing activities for the three months ended March 31, 2022 Cash Flow Summary (For the Three Months Ended March 31, 2022) | Activity | Amount | | :--- | :--- | | Net cash used in operating activities | $(449,940) | | Net cash provided by financing activities | $300,000 | | **Net change in cash** | **$(149,940)** | | Cash - Beginning of period | $154,942 | | **Cash - End of period** | **$5,002** | - The company used approximately **$450,000** in cash for operations, which was partially funded by a **$300,000** loan from its sponsor, resulting in a net cash decrease of about **$150,000** for the quarter[19](index=19&type=chunk) [Notes to Financial Statements](index=8&type=section&id=Notes%20to%20Financial%20Statements) This section provides additional information and explanations on the company's financial position, operations, and accounting policies - The company is a SPAC that consummated its IPO in August 2021, raising aggregate proceeds of **$57.3 million** which are held in a trust account. It has not commenced core operations and will not generate operating revenue until after an Initial Business Combination[22](index=22&type=chunk)[23](index=23&type=chunk)[27](index=27&type=chunk) - On January 27, 2022, the Company entered into a Merger Agreement with Apifiny Group Inc. The merger is subject to stockholder approval and other closing conditions[87](index=87&type=chunk)[88](index=88&type=chunk) - The company has a working capital deficit of **$1.6 million** and cash of **$5,002** as of March 31, 2022, which raises substantial doubt about its ability to continue as a going concern[42](index=42&type=chunk)[43](index=43&type=chunk) - Private Warrants are accounted for as a derivative liability at fair value, which decreased from **$170,867 to $103,109** during the quarter, resulting in a non-cash gain of **$67,758**[54](index=54&type=chunk)[131](index=131&type=chunk)[134](index=134&type=chunk) - Subsequent to the quarter end, on April 4, 2022, the company received an additional **$500,000** via a convertible promissory note from its Sponsor for operating expenses[136](index=136&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=31&type=section&id=ITEM%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses the company's financial condition, operational results, and liquidity, highlighting the net loss and going concern uncertainties - The company is a blank check company formed for the purpose of a business combination and has not commenced core operations as of March 31, 2022[142](index=142&type=chunk)[143](index=143&type=chunk) - For the three months ended March 31, 2022, the company reported a net loss of **$1,322,607**, consisting of **$1,395,709** in operating costs, offset by **$5,344** in interest income and a **$67,758** gain on the change in fair value of warrant liability[151](index=151&type=chunk) - Management has concluded that the company's working capital deficit of **$1,602,564** and low cash balance raise substantial doubt about its ability to continue as a going concern through the next year or until a business combination is consummated[154](index=154&type=chunk)[157](index=157&type=chunk) - The company entered into a definitive Merger Agreement with Apifiny Group Inc. on January 27, 2022, which is the company's primary focus[148](index=148&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=35&type=section&id=ITEM%203.%20Quantitative%20and%20Qualitative%20Disclosures%20about%20Market%20Risk) The company is a smaller reporting company and is not required to provide the information requested under this item - As a smaller reporting company, ABRI SPAC I, Inc. is not required to make disclosures under this item[165](index=165&type=chunk) [Controls and Procedures](index=35&type=section&id=ITEM%204.%20Controls%20and%20Procedures) Management concluded that the company's disclosure controls and procedures were effective, with no material changes in internal control over financial reporting - Based on an evaluation as of March 31, 2022, the company's principal executive officer and principal financial officer concluded that disclosure controls and procedures were effective[167](index=167&type=chunk) - There were no material changes in the company's internal control over financial reporting during the most recent fiscal quarter[169](index=169&type=chunk) [PART II. OTHER INFORMATION](index=36&type=section&id=PART%20II.%20OTHER%20INFORMATION) This section provides additional information including legal proceedings, risk factors, equity sales, and other disclosures [Legal Proceedings](index=36&type=section&id=ITEM%201.%20Legal%20Proceedings) The company reports that there are no legal proceedings - The company has no legal proceedings to report[171](index=171&type=chunk) [Risk Factors](index=36&type=section&id=ITEM%201A.%20Risk%20Factors) This section highlights increased SPAC competition and potential adverse effects from proposed SEC rules on business combination completion - Increased competition from a substantial number of SPACs may make it more difficult and costly to find and complete an initial business combination[173](index=173&type=chunk)[174](index=174&type=chunk) - Proposed SEC rules issued on March 30, 2022, relating to SPACs could, if adopted, materially and adversely affect the company's ability to negotiate and complete its business combination and may increase associated costs and time[176](index=176&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=37&type=section&id=ITEM%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) This section details the private placement of units to the Sponsor and the deposit of IPO and private placement proceeds into a trust account - Simultaneously with the IPO, the Sponsor purchased **276,250** Private Units at **$10.00** per unit. An additional **18,348** Private Units were purchased in connection with the over-allotment option exercise[178](index=178&type=chunk)[179](index=179&type=chunk) - As of August 23, 2021, a total of **$57,339,200** from the IPO and Private Placement proceeds were deposited in the company's trust account[179](index=179&type=chunk) [Defaults Upon Senior Securities](index=37&type=section&id=ITEM%203.%20Defaults%20Upon%20Senior%20Securities) The company reports no defaults upon senior securities - None[182](index=182&type=chunk) [Mine Safety Disclosures](index=37&type=section&id=ITEM%204.%20Mine%20Safety%20Disclosures) This section is not applicable to the company - Not applicable[183](index=183&type=chunk) [Other Information](index=37&type=section&id=ITEM%205.%20Other%20Information) The company reports no other information - None[184](index=184&type=chunk) [Exhibits](index=38&type=section&id=ITEM%206.%20Exhibits) This section lists the exhibits filed as part of the Quarterly Report, including officer certifications and Inline XBRL data files - The exhibits filed with this report include Certifications of the Principal Executive Officer and Principal Financial Officer pursuant to the Sarbanes-Oxley Act of 2002, and Inline XBRL documents[186](index=186&type=chunk)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to ________________ Commission file number: 001-40723 ABRI SPAC I, INC. (Exact name of registrant as specified in its charter) | --- | |------------------------------ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number: 001-40723 ABRI SPAC I, INC. (Exact Name of Registrant as Specified in Its Charter) | --- | |------------------------------------| | ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40723 ABRI SPAC I, INC. (Exact Name of Registrant as Specified in Its Charter) | --- | --- | --- | --- | |---------------------------------- ...